entertainment -WSS

entertainment

author：knowledge 2025-09-06 04:50:56 - browse：5133

The New York Stock Exchange (NYSE) — Spencer Platt/Getty Images

Biohaven Pharmaceuticals said Wednesday that a new type of experimental medicine reduced levels of a disease-causing immune molecule by up to 37% in an early-stage study of human volunteers — a result that the company called “positive” as a proof of concept but that also fell short of investor expectations.

The drug, called BHV-1300, belongs to a new class of antibody medicines that shuttle harmful proteins to the liver so they can be removed from the body. BHV-1300 is specifically designed to reduce levels of an autoantibody called IgG that is implicated in rheumatoid arthritis, myasthenia gravis, and other autoimmune disorders.

In its Phase 1 study, Biohaven tested four escalating doses of BHV-1300 in healthy volunteers, showing a reduction in levels of IgG of 5%, 15%, 30%, and 37%, respectively, the company said. The reductions in IgG levels, which occurred relatively quickly in just four to five days, did not cause significant, adverse changes in liver enzyme levels, Biohaven added — an important safety check given the mechanism of the drug.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Medical experts are missing from AI regulatory conversations

Wikipedia

WSS

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Court strikes down limits on filming of police in Arizona

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Trump got a 'target letter.' What is one and what does it mean?

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Medical records are filled with copy

In new study, freeze

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AbbVie dramatically boosts its spending on lobbying

Sports medicine is finally prioritizing gender equality

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Affirmative action in medical school literally saved lives

Court strikes down limits on filming of police in Arizona

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

HIPAA doesn't protect reproductive records from prosecutors

Wikipedia

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Plane’s emergency slide plummets from sky, hits Chicago home

Celebrate National Dole Whip Day for 3 days this week at Disney

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

In new study, freeze

Wikipedia

hotspot

Wikipedia

Wikipedia